Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Authors
Keywords
-
Journal
Microbial Cell Factories
Volume 10, Issue Suppl 1, Pages S4
Publisher
Springer Nature
Online
2011-08-31
DOI
10.1186/1475-2859-10-s1-s4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lactobacillus acidophilus as a live vehicle for oral immunization against chicken anemia virus
- (2010) Hassan Moeini et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice
- (2010) Tae-Young Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lactococcus lactis as a Cell Factory for Delivery of Therapeutic Proteins
- (2010) Mohammed Bahey-El-Din et al. CURRENT GENE THERAPY
- Lactococcus lactisas a live vector for mucosal delivery of therapeutic proteins
- (2010) Luis G. Bermúdez-Humarán Human vaccines & immunotherapeutics
- Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice
- (2010) Laurie Watterlot et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination
- (2010) Qiuxiang Zhang et al. MICROBIOLOGICAL RESEARCH
- Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules
- (2010) Han Lei et al. VIROLOGY
- Lactococcus lactis Expressing either Staphylococcus aureus Fibronectin-Binding Protein A or Listeria monocytogenes Internalin A Can Efficiently Internalize and Deliver DNA in Human Epithelial Cells
- (2009) S. Innocentin et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Perspectives for the development of human papillomavirus vaccines and immunotherapy
- (2009) Luis G Bermúdez-Humarán et al. Expert Review of Vaccines
- Allergy Therapy by Intranasal Administration with Recombinant Lactococcus lactis Producing Bovine β-Lactoglobulin
- (2009) Naima G. Cortes-Perez et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Influence of the route of administration on immunomodulatory properties of bovine β-lactoglobulin-producing Lactobacillus casei
- (2009) S. Hazebrouck et al. VACCINE
- Oral Immunization with Recombinant Lactobacillus plantarum Induces a Protective Immune Response in Mice with Lyme Disease
- (2008) B. del Rio et al. Clinical and Vaccine Immunology
- In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells
- (2008) J-M Chatel et al. GENE THERAPY
- Nasal Immunization with Lactococcus lactis Expressing the Pneumococcal Protective Protein A Induces Protective Immunity in Mice
- (2008) M. Medina et al. INFECTION AND IMMUNITY
- Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
- (2008) Jerry M. Wells et al. NATURE REVIEWS MICROBIOLOGY
- Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen
- (2008) Adrian C.N. Sim et al. VACCINE
- Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model
- (2008) Mohammed Bahey-El-Din et al. VACCINE
- Production of biologically active CXC chemokines by Lactococcus lactis: Evaluation of its potential as a novel mucosal vaccine adjuvant
- (2008) Naima G. Cortes-Perez et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now